Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
Zhu Y, Guo X, Zhang Q, Yang Y. Prognostic value of sarcopenia in patients with rectal cancer: a meta-analysis. PLoS One [Internet]. 2022;17(6 June):1–11. https://doi.org/10.1371/journal.pone.0270332.
Thormann M, Omari J, Pech M, Damm R, Croner R, Perrakis A, et al. Low skeletal muscle mass and post-operative complications after surgery for liver malignancies: a meta-analysis. Langenbeck’s Arch Surg [Internet]. 2022;407(4):1369–79. https://doi.org/10.1007/s00423-022-02541-5.
Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer [Internet]. 2016;57:58–67. https://doi.org/10.1016/j.ejca.2015.12.030.
Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr. 2018;37(4):1101–13.
Kirk B, Cawthon PM, Arai H, Ávila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in sarcopenia (GLIS). Age Ageing. 2024;53(afae052):1–10.
Levolger S, Van Vugt JLA, De Bruin RWF, IJzermans JNM. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg. 2015;102(12):1448–58.
Reisinger KW, Van Vugt JLA, Tegels JJW, Snijders C, Hulsewé KWE, Hoofwijk AGM, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2015;261(2):345–52.
Luo L, Fan Y, Wang Y, Wang Z, Zhou J. Prevalence and clinical outcomes of sarcopenia in patients with esophageal, gastric or colorectal cancers receiving preoperative neoadjuvant therapy: a meta-analysis. Asia-Pacific J Oncol Nurs [Internet]. 2024;11(4):100436. https://doi.org/10.1016/j.apjon.2024.100436.
Yoshimura Y, Wakabayashi H. Interventions for treating sarcopenia: a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc [Internet]. 2017;18(6):553.e1–553.e16. https://doi.org/10.1016/j.jamda.2017.03.019.
Pesce A, Fabbri N, Colombari S, Uccellatori L, Grazzi G, Lordi R, et al. A randomized controlled clinical trial on multimodal prehabilitation in colorectal cancer patients to improve functional capacity: preliminary results. Surg Endosc [Internet]. 2024;38(12):7440–50. https://doi.org/10.1007/s00464-024-11198-8.
Belbasis L, Bellou V, Ioannidis JPA. Conducting umbrella reviews. BMJ Med. 2022;1(1):e000071.
PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https://doi.org/10.1136/bmj.n71
Muka T, Glisic M, Milic J, Verhoog S, Bohlius J, Bramer W, et al. A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research. Eur J Epidemiol [Internet]. 2020;35(1):49–60. https://doi.org/10.1007/s10654-019-00576-5.
Teperikidis L, Boulmpou A, Papadoloulos C, Biondi-Zoccai G. Using ChatGPT to perform a systematic review: a tutorial. Minerva Cardiol Angiol. 2024;6:547–67.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev [Internet]. 2016;5(1):1–10. https://doi.org/10.1186/s13643-016-0384-4.
Siontis KC, Hernandez-Boussard T, Ioannidis JPA. Overlapping meta-analyses on the same topic: survey of published studies. BMJ. 2013;347(7921):1–11.
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:1–9.
Harrison S, Jones HE, Martin RM, Lewis SJ, Higgins JPT. The albatross plot: a novel graphical tool for presenting results of diversely reported studies in a systematic review. Res Synth Methods. 2017;8(3):281–9.
PubMed PubMed Central Google Scholar
Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based Ment Health. 2018;21(3):95–100.
PubMed PubMed Central Google Scholar
Gosling CJ, Solanes A, Fusar-Poli P, Radua J. Metaumbrella: the first comprehensive suite to perform data analysis in umbrella reviews with stratification of the evidence. BMJ Ment Heal. 2023;26(1):1–8.
Zhang G, Meng S, Li R, Ye J, Zhao L. Clinical significance of sarcopenia in the treatment of patients with primary hepatic malignancies, a systematic review and meta-analysis. Oncotarget. 2017;8(60):102474–85.
PubMed PubMed Central Google Scholar
Boshier PR, Heneghan R, Markar SR, Baracos VE, Low DE. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2018;31(8):1–11.
Simonsen C, De Heer P, Bjerre ED, Suetta C, Hojman P, Pedersen BK, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology. Ann Surg. 2018;268(1):58–69.
Mintziras I, Miligkos M, Wächter S, Manoharan J, Maurer E, Bartsch DK. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis. Int J Surg [Internet]. 2018;59(June):19–26. https://doi.org/10.1016/j.ijsu.2018.09.014.
Chang KV, De CJ, Wu WT, Huang KC, Hsu CT, Han DS. Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer. 2018;7(1):90–103.
Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X, et al. Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis. 2018;33(10):1419–27.
Yang Z, Zhou X, Ma B, Xing Y, Jiang X, Wang Z. Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg. 2018;22(11):1890–902.
Deng HY, Zha P, Peng L, Hou L, Huang KL, Li XY. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis. Dis Esophagus. 2019;32(3):1–10.
Hua H, Xu X, Tang Y, Ren Z, Xu Q, Chen L. Effect of sarcopenia on clinical outcomes following digestive carcinoma surgery: a meta-analysis. Support Care Cancer. 2019;27(7):2385–94.
Bundred J, Kamarajah SK, Roberts KJ. Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. Hpb [Internet]. 2019;21(12):1603–12. https://doi.org/10.1016/j.hpb.2019.05.018.
Rinninella E, Cintoni M, Raoul P, Pozzo C, Strippoli A, Bria E, et al. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis. Clin Nutr [Internet]. 2020;39(7):2045–54. https://doi.org/10.1016/j.clnu.2019.10.021.
Cao Q, Xiong Y, Zhong Z, Ye Q. Computed tomography-assessed sarcopenia indexes predict major complications following surgery for hepatopancreatobiliary malignancy: a meta-analysis. Ann Nutr Metab. 2019;74(1):24–34.
Su H, Ruan J, Chen T, Lin E, Shi L. CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging. 2019;19(1):1–15.
Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019;22:10–22.
Xu L, Jing Y, Zhao C, Zhang Q, Zhao X, Yang J, et al. Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following hepatectomy: a meta-analysis. J Gastrointest Oncol. 2020;11(5):1040–53.
PubMed PubMed Central Google Scholar
Lee CM, Kang J. Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11(5):1270–82.
PubMed PubMed Central Google Scholar
Wang PY, Xu LD, Chen XK, Xu L, Yu YK, Zhang RX, et al. Sarcopenia and short-term outcomes after esophagectomy: a meta-analysis. Ann Surg Oncol. 2020;27(8):3041–51.
Borggreve AS, den Boer RB, van Boxel GI, de Jong PA, Veldhuis WB, Steenhagen E, van Hillegersberg R, Ruurda JP. The predictive value of low muscle mass as measured on CT scans for postoperative complications and mortality in gastric cancer patients: a systematic review and meta-analysis. J Clin Med. 2020;9(1):199. https://doi.org/10.3390/jcm9010199.
PubMed PubMed Central Google Scholar
Schizas D, Frountzas M, Lidoriki I, Spartalis E, Toutouzas K, Dimitroulis D, et al. Sarcopenia does not affect postoperative complication rates in oesophageal cancer surgery : a systematic review and meta-analysis. Ann R Coll Surg Engl. 2020;102:120–32.
Guan J, Yang Q, Chen C, Wang G, Zhu H. Prognostic value of low skeletal muscle mass in hepatocellular carcinoma patients treated with sorafenib or lenvatinib: a meta-analysis. EXCLI J. 2021;20:1–16.
PubMed PubMed Central Google Scholar
Xie H, Wei L, Liu M, Yuan G, Tang S, Gan J. Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis. Langenbeck’s Arch Surg. 2021;406(6):1775–88.
Comments (0)